| ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib (NCT00272987) | Novartis Pharmaceuticals | 2005-12-13 |
| Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer (NCT00263588) | Novartis Pharmaceuticals | 2005-12-02 |
| Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer (NCT00242567) | Novartis Pharmaceuticals | 2005-12-01 |
| Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer (NCT00248170) | Novartis Pharmaceuticals | 2005-12-01 |
| Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly (NCT00372697) | Novartis Pharmaceuticals | 2005-12-01 |
| Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation (NCT00377962) | Novartis Pharmaceuticals | 2005-12-01 |
| Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients (NCT00669942) | Novartis Pharmaceuticals | 2005-12-01 |
| Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer (NCT00219297) | Novartis Pharmaceuticals | 2005-11-16 |
| Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy (NCT00248157) | Novartis Pharmaceuticals | 2005-11-01 |
| A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes (NCT00260156) | Novartis Pharmaceuticals | 2005-11-01 |
| Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy (NCT00248131) | Novartis Pharmaceuticals | 2005-11-01 |
| RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency (NCT00267189) | Novartis Pharmaceuticals | 2005-11-01 |
| Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Simultaneous Pancreas-Kidney Transplants (NCT00267150) | Novartis Pharmaceuticals | 2005-11-01 |
| Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer (NCT00262990) | Novartis Pharmaceuticals | 2005-11-01 |
| Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension (NCT00267176) | Novartis Pharmaceuticals | 2005-11-01 |
| Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients. (NCT00332839) | Novartis Pharmaceuticals | 2005-11-01 |
| Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer (NCT00329940) | Novartis Pharmaceuticals | 2005-11-01 |
| The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss (NCT00375505) | Novartis Pharmaceuticals | 2005-10-01 |
| Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension (NCT00219141) | Novartis Pharmaceuticals | 2005-10-01 |
| Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload (NCT00235391) | Novartis Pharmaceuticals | 2005-10-01 |
| GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer (NCT00251433) | Novartis Pharmaceuticals | 2005-09-26 |
| Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis (NCT00332696) | Novartis Pharmaceuticals | 2005-09-01 |
| Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma (NCT00231166) | Novartis Pharmaceuticals | 2005-09-01 |
| A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib (NCT00242580) | Novartis Pharmaceuticals | 2005-09-01 |
| Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma (NCT00332969) | Novartis Pharmaceuticals | 2005-09-01 |
| Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients (NCT00229138) | Novartis Pharmaceuticals | 2005-09-01 |
| Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation (NCT00239005) | Novartis Pharmaceuticals | 2005-09-01 |
| Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients (NCT00117507) | Novartis Pharmaceuticals | 2005-09-01 |
| Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study) (NCT01279473) | Novartis Pharmaceuticals | 2005-08-01 |
| Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST) (NCT00135005) | Novartis Pharmaceuticals | 2005-08-01 |
| Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors (NCT00417807) | Novartis Pharmaceuticals | 2005-08-01 |
| Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients (NCT00110266) | Novartis Pharmaceuticals | 2005-07-25 |
| Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT00124280) | Novartis Pharmaceuticals | 2005-07-01 |
| Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity) (NCT00124748) | Novartis Pharmaceuticals | 2005-06-01 |
| Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients (NCT00154297) | Novartis Pharmaceuticals | 2005-06-01 |
| Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function (NCT00386750) | Novartis Pharmaceuticals | 2005-06-01 |
| Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate Cancer (NCT00375648) | Novartis Pharmaceuticals | 2005-06-01 |
| Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration) (NCT00171301) | Novartis Pharmaceuticals | 2005-06-01 |
| Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD) (NCT00411580) | Novartis Pharmaceuticals | 2005-06-01 |
| Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy (NCT00456833) | Novartis Pharmaceuticals | 2005-06-01 |
| A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes (NCT00351507) | Novartis Pharmaceuticals | 2005-05-01 |
| A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALL (NCT00384228) | Novartis Pharmaceuticals | 2005-05-01 |
| Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients (NCT00239876) | Novartis Pharmaceuticals | 2005-05-01 |
| Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients (NCT00110617) | Novartis Pharmaceuticals | 2005-05-01 |
| A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer (NCT00171704) | Novartis Pharmaceuticals | 2005-04-01 |
| A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload (NCT00171821) | Novartis Pharmaceuticals | 2005-04-01 |
| Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) (NCT00171899) | Novartis Pharmaceuticals | 2005-04-01 |
| Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy (NCT00108108) | Novartis Pharmaceuticals | 2005-04-01 |
| Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer (NCT00171808) | Novartis Pharmaceuticals | 2005-04-01 |
| A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies (NCT00109707) | Novartis Pharmaceuticals | 2005-04-01 |
| Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting (NCT00509990) | Novartis Pharmaceuticals | 2005-04-01 |
| Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes (NCT00110240) | Novartis Pharmaceuticals | 2005-04-01 |
| A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) (NCT00172042) | Novartis Pharmaceuticals | 2005-03-01 |
| Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies (NCT00142298) | Novartis Pharmaceuticals | 2005-03-01 |
| Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women (NCT00107016) | Novartis Pharmaceuticals | 2005-03-01 |
| Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder (NCT00108836) | Novartis Pharmaceuticals | 2005-03-01 |
| Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis. (NCT00170911) | Novartis Pharmaceuticals | 2005-03-01 |
| Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes (NCT00106340) | Novartis Pharmaceuticals | 2005-03-01 |
| ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients (NCT00170846) | Novartis Pharmaceuticals | 2005-02-01 |
| Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen (NCT00170820) | Novartis Pharmaceuticals | 2005-02-01 |
| Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection (NCT00098059) | Novartis Pharmaceuticals | 2005-02-01 |
| Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients (NCT00149903) | Novartis Pharmaceuticals | 2005-01-01 |
| Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms (NCT00487708) | Novartis Pharmaceuticals | 2005-01-01 |
| Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease (NCT00219284) | Novartis Pharmaceuticals | 2005-01-01 |
| Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes (NCT00101803) | Novartis Pharmaceuticals | 2005-01-01 |
| Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes (NCT00102466) | Novartis Pharmaceuticals | 2005-01-01 |
| Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes (NCT00102388) | Novartis Pharmaceuticals | 2005-01-01 |
| Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant (NCT00099801) | Novartis Pharmaceuticals | 2005-01-01 |
| Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients (NCT00150046) | Novartis Pharmaceuticals | 2004-12-01 |
| Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old (NCT00510003) | Novartis Pharmaceuticals | 2004-12-01 |
| Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy (NCT00172055) | Novartis Pharmaceuticals | 2004-12-01 |
| Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension (NCT00136851) | Novartis Pharmaceuticals | 2004-12-01 |
| Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee (NCT00371670) | Novartis Pharmaceuticals | 2004-12-01 |
| Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder (NCT00107939) | Novartis Pharmaceuticals | 2004-11-01 |
| Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder (NCT00099229) | Novartis Pharmaceuticals | 2004-11-01 |
| Non-small Cell Lung Cancer Registry (NCT00099541) | Novartis Pharmaceuticals | 2004-11-01 |
| The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS) (NCT00171431) | Novartis Pharmaceuticals | 2004-11-01 |
| Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients (NCT00239798) | Novartis Pharmaceuticals | 2004-11-01 |
| Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease (NCT00134979) | Novartis Pharmaceuticals | 2004-10-01 |
| Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder (NCT00107926) | Novartis Pharmaceuticals | 2004-10-01 |
| Efficacy and Safety of Imatinib in Chordoma (NCT00150072) | Novartis Pharmaceuticals | 2004-10-01 |
| Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma (NCT00154375) | Novartis Pharmaceuticals | 2004-10-01 |
| A Multiple Myeloma Trial in Patients With Bone Metastases (NCT00104104) | Novartis Pharmaceuticals | 2004-10-01 |
| Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria (NCT00097955) | Novartis Pharmaceuticals | 2004-10-01 |
| An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload (NCT00171210) | Novartis Pharmaceuticals | 2004-10-01 |
| Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia (NCT00101712) | Novartis Pharmaceuticals | 2004-10-01 |
| Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients (NCT00154206) | Novartis Pharmaceuticals | 2004-09-01 |
| Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes (NCT00171912) | Novartis Pharmaceuticals | 2004-09-01 |
| Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients. (NCT00170794) | Novartis Pharmaceuticals | 2004-09-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of TKI258 in Subjects With Acute Myeloid Leukemia (NCT00279773) | Novartis Pharmaceuticals | 2004-09-01 |
| Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy (NCT00099268) | Novartis Pharmaceuticals | 2004-09-01 |
| Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis (NCT00172003) | Novartis Pharmaceuticals | 2004-09-01 |
| An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly (NCT00171730) | Novartis Pharmaceuticals | 2004-08-24 |
| Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease (NCT00171951) | Novartis Pharmaceuticals | 2004-08-13 |
| A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients (NCT00098007) | Novartis Pharmaceuticals | 2004-08-09 |
| Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate (NCT00093639) | Novartis Pharmaceuticals | 2004-08-01 |
| Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy (NCT00097968) | Novartis Pharmaceuticals | 2004-08-01 |
| Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients (NCT00170859) | Novartis Pharmaceuticals | 2004-08-01 |
| Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older (NCT00132808) | Novartis Pharmaceuticals | 2004-07-01 |
| Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00098228) | Novartis Pharmaceuticals | 2004-07-01 |